Literature DB >> 9580596

Open state block by fendiline of L-type Ca++ channels in ventricular myocytes from rat heart.

H Nawrath1, G Klein, J Rupp, J W Wegener, A Shainberg.   

Abstract

The effects of fendiline on L-type Ca++ currents [ICa(L)] were investigated in rat ventricular cardiomyocytes using the patch-clamp technique both in the whole-cell disrupted-patch and in the cell-attached configuration. For comparison, the effects of verapamil were also investigated. Both compounds depressed the magnitude of whole cell ICa(L), verapamil being about 15 times more potent than fendiline. Verapamil did not change the time course of the current, whereas fendiline accelerated its decay when either Ca++ or Ba++ ions were used as charge carriers. In the presence of the Ca++ agonist BayK8644 (10 microM), the potency ratio of fendiline/verapamil was inverted. BayK8644 (10 microM) also reversed the potency ratio of verapamil/fendiline in smooth muscle, with respect to changes in tension induced by K+ (48 mM). In single channel recordings at 0.1 Hz, in the presence of BayK8644 (1 microM) and using Ba++ ions as the charge carrier, fendiline (1 microM) reduced mean open time by 34% and channel availability by 8%; the ensemble average current of Ca++ channels was reduced by 43%. In the same experimental conditions, verapamil (1 microM) was ineffective. These results can be explained by the assumption that fendiline blocks Ca++ channels preferentially in the open state, in contrast to verapamil which blocks preferentially inactivated Ca++ channels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580596

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Barnidipine block of L-type Ca(2+) channel currents in rat ventricular cardiomyocytes.

Authors:  J W Wegener; H Meyrer; J Rupp; H Nawrath
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice.

Authors:  Ryuichiro Yamamoto; Masaki Matsushita; Hiroshi Kitoh; Akio Masuda; Mikako Ito; Takenobu Katagiri; Tatsushi Kawai; Naoki Ishiguro; Kinji Ohno
Journal:  J Bone Miner Metab       Date:  2012-08-24       Impact factor: 2.626

Review 3.  Clinical potential of GABAB receptor modulators.

Authors:  Jennifer Ong; David I B Kerr
Journal:  CNS Drug Rev       Date:  2005

4.  Block and modified gating of cardiac calcium channel currents by terodiline.

Authors:  T Ogura; S Jones; L M Shuba; J R McCullough; T F McDonald
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

5.  Diclofenac, a Non-steroidal Anti-inflammatory Drug, Inhibits L-type Ca Channels in Neonatal Rat Ventricular Cardiomyocytes.

Authors:  Oleg V Yarishkin; Eun Mi Hwang; Donggyu Kim; Jae Cheal Yoo; Sang Soo Kang; Deok Ryoung Kim; Jae-Hee-Jung Shin; Hye-Joo Chung; Ho-Sang Jeong; Dawon Kang; Jaehee Han; Jae-Yong Park; Seong-Geun Hong
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

6.  Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission.

Authors:  Dharini van der Hoeven; Kwang-jin Cho; Xiaoping Ma; Sravanthi Chigurupati; Robert G Parton; John F Hancock
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

7.  Effect of fendiline on the maintenance and expression of methamphetamine-induced conditioned place preference in Sprague-Dawley rats.

Authors:  Robin M Voigt; Jennifer L Riddle; T Celeste Napier
Journal:  Psychopharmacology (Berl)       Date:  2013-11-22       Impact factor: 4.530

Review 8.  Enhanced Late Na and Ca Currents as Effective Antiarrhythmic Drug Targets.

Authors:  Hrayr S Karagueuzian; Arash Pezhouman; Marina Angelini; Riccardo Olcese
Journal:  Front Pharmacol       Date:  2017-02-06       Impact factor: 5.810

9.  Development of phenotypic assays for identifying novel blockers of L-type calcium channels in neurons.

Authors:  Rebecca Hagan; Elizabeth Rex; David Woody; Monika Milewski; Thomas Glaza; Michael P Maher; Yi Liu
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.